Home › Drug Codes › Q Codes › Q0167 · DRONABINOL
Updated July 1st, 2026

DRONABINOL Q Code: Q0167

Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for Q0167, effective October 1, 2026: $2.092 per HCPCS billing unit, up 11.9% from $1.869. From CMS's final file.

?
Medicare Payment Limit ?
$1.869
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
12
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
HCPCS Added Date April 1, 1998
Manufacturer Multiple Manufacturers
Route of Administration Oral
Generic Status Multi-Source; Generic
Dosage Form Capsule

About DRONABINOL

Dronabinol is a medication aligned to the HCPCS Q Code: Q0167 for billing, pricing, and reimbursement purposes in the United States. This Anti-Emetic medication is administered via the oral route and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 12 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00904-7144-61 Dronabinol Major Pharmaceuticals 100 2.5 MG
00904-7145-04 Dronabinol Major Pharmaceuticals 60 5 MG
53097-0571-60 Marinol ThePharmaNetwork, LLC 60 2.5 MG
67877-0753-60 Dronabinol Ascend Laboratories, LLC 60 2.5 MG
67877-0755-60 Dronabinol Ascend Laboratories, LLC 240 10 MG
•••••-••••-•• Log in to view DRONABINOL
DRONABINOL
DRONABINOL
Login to view 7 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

DRONABINOL Pricing & Reimbursement

Q0167 Private Payer Reimbursement
$1.29 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

DRONABINOL Medically Unlikely Edits (MUE)

The most billing units of Q0167 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 2.5 mg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
0 units / day
Not payable in this setting
Hospital Outpatient
108 units / day
= 270 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.
Not on the CMS JW / JZ list

CMS does not include Dronabinol (Q0167) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q0167. Wastage billing guide →

DRONABINOL Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS) Nausea and vomiting associated with cancer chemotherapy anorexia associated with weight loss in patients with AIDS nausea and vomiting associated with cancer chemotherapy
Drug Class
Cannabinoid [EPC]Cannabinoids [CS]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Dronabinol billing and coding guide?
We have not yet identified a manufacturer source of Dronabinol billing and coding information.
Are there any available Dronabinol patient assistance programs?
Our team did not identify a source for Dronabinol patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Dronabinol prescribing information?
DRONABINOL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Dronabinol side effect information?
Our team has not yet identified a source of side effects information for DRONABINOL. Please check back in a few weeks.
Does billing DRONABINOL require JZ/JW wastage modifiers?
CMS does not include DRONABINOL (Q0167) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q0167. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to DRONABINOL.

Q0155SyndrosDronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimenBenuvia TherapeuticsAdded January 1, 2025C9145APONVIEInjection, aprepitant, (aponvie), 1 mgHeron TherapeuticsAdded April 1, 2023C9153BARHEMSYSInjection, amisulpride, 1 mgAcacia PharmaAdded October 1, 2023J0184BARHEMSYSInjection, amisulpride, 1 mgAcacia PharmaAdded January 1, 2024J0185CINVANTIInjection, aprepitant, 1 mgHeron TherapeuticsAdded January 1, 2019J0207ETHYOLInjection, amifostine, 500 mgLegacy PharmaAdded January 1, 1998J0791ADAKVEOInjection, crizanlizumab-tmca, 5 mgNovartisAdded July 1, 2020J1260ANZEMETInjection, dolasetron mesylate, 10 mgSanofiAdded January 1, 1999J1453EMENDInjection, fosaprepitant, 1 mgMultiple ManufacturersAdded January 1, 2009J1454AKYNZEOInjection, fosnetupitant 235 mg and palonosetron 0.25 mgHelsinn Therapeutics USAdded January 1, 2019